Stress Perfusion Coronary Flow Reserve Versus Cardiac Magnetic Resonance for Known or Suspected CAD

Journal of the American College of Cardiology

Volumn 70, Issue 7, 2017, Pages 869-879

  Kato, Shingo ^a   Saito, Naka ^a   Nakachi, Tatsuya ^a   Fukui, Kazuki ^a   Iwasawa, Tae ^a   Taguri, Masataka ^b   Kosuge, Masami ^c   Kimura, Kazuo ^c  

^a Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

coronary artery disease; coronary flow reserve; magnetic resonance imaging; prognostic value; stress perfusion CMR

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CINE MAGNETIC RESONANCE IMAGING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; CORONARY SINUS; DYSPNEA; FEMALE; HEART; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART PALPITATION; HEART RATE; HUMAN; IMAGE ANALYSIS; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; AGED; CORONARY ARTERY BLOOD FLOW; EXERCISE TEST; FOLLOW UP; FRACTIONAL FLOW RESERVE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RETROSPECTIVE STUDY;

AGED; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 85025821082     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.06.028     Document Type: Article

References (24)

1. Benjamin, E.J., Blaha, M.J., Chiuve, S.E., et al. Heart disease and stroke statistics — 2017 update: a report from the American Heart Association. Circulation 135 (2017), e146–e603.
2. Tonino, P.A., De Bruyne, B., Pijls, N.H., et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360 (2009), 213–224.
3. De Bruyne, B., Fearon, W.F., Pijls, N.H., et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371 (2014), 1208–1217.
4. Murthy, V.L., Naya, M., Foster, C.R., et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 124 (2011), 2215–2224.
5. Ziadi, M.C., Dekemp, R.A., Williams, K.A., et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 58 (2011), 740–748.
6. Herzog, B.A., Husmann, L., Valenta, I., et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 54 (2009), 150–156.
7. Schwitter, J., DeMarco, T., Kneifel, S., et al. Magnetic resonance–based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Circulation 101 (2000), 2696–2702.
8. van Rossum, A.C., Visser, F.C., Hofman, M.B., Galjee, M.A., Westerhof, N., Valk, J., Global left ventricular perfusion: noninvasive measurement with cine MR imaging and phase velocity mapping of coronary venous outflow. Radiology 182 (1992), 685–691.
9. Kato, S., Saito, N., Kirigaya, H., et al. Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction. J Am Heart Assoc, 5, 2016, e002649.
10. Thygesen, K., Alpert, J.S., White, H.D., Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007), 2173–2195.
11. Semelka, R.C., Tomei, E., Wagner, S., et al. Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging. Radiology 174 (1990), 763–768.
12. Czernin, J., Muller, P., Chan, S., et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88 (1993), 62–69.
13. Naya, M., Tsukamoto, T., Morita, K., et al. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. J Am Coll Cardiol 50 (2007), 1144–1149.
14. Shah, R., Heydari, B., Coelho-Filho, O., et al. Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation 128 (2013), 605–614.
15. Shaw, L.J., Berman, D.S., Maron, D.J., et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117 (2008), 1283–1291.
16. Greenwood, J.P., Maredia, N., Younger, J.F., et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379 (2012), 453–460.
17. Jahnke, C., Nagel, E., Gebker, R., et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115 (2007), 1769–1776.
18. Steel, K., Broderick, R., Gandla, V., et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation 120 (2009), 1390–1400.
19. Greenwood, J.P., Herzog, B.A., Brown, J.M., et al. Prognostic value of cardiovascular magnetic resonance and single-photon emission computed tomography in suspected coronary heart disease: long-term follow-up of a prospective, diagnostic accuracy cohort study. Ann Intern 165 (2016), 1–9.
20. Laine, H., Raitakari, O.T., Niinikoski, H., et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 32 (1998), 147–153.
21. Prior, J.O., Quinones, M.J., Hernandez-Pampaloni, M., et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 111 (2005), 2291–2298.
22. Campisi, R., Czernin, J., Schoder, H., Sayre, J.W., Schelbert, H.R., L-Arginine normalizes coronary vasomotion in long-term smokers. Circulation 99 (1999), 491–497.
23. Kaufmann, P.A., Gnecchi-Ruscone, T., Schafers, K.P., Luscher, T.F., Camici, P.G., Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 36 (2000), 103–109.
24. Charytan, D.M., Shelbert, H.R., Di Carli, M.F., Coronary microvascular function in early chronic kidney disease. Circ Cardiovasc Imaging 3 (2010), 663–671.